Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec

Zurich / Montréal, November 26, 2018 As part of the ongoing commitment of Montréal InVivo to promote the economic development and growth of the life sciences and health technologies (LSHT) sector in Québec, Biotechgate, a company owned by Venture Valuation, and Montréal InVivo, the LSHT industrial cluster of the Montreal metropolitan area, announce a partnership … Continue reading Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec

Read more

Site Selection Report for Life Sciences Companies in Europe 2018

The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Interviews with leading Life Sciences companies: tella inc.

Leveraging its proprietary technology of culturing highly purified dendritic cells (DCs), tella is developing, as its first immunotherapeutic product, a DC-based vaccine in combination with WT1 (Wilms’ tumor gene 1) antigen for inoperable pancreatic cancer. Venture Valuation (VV) interviewed Dr. Yuichiro Yazaki, President and CEO. Read the interview

Read more